- Adults 18-60 years- Maintenance starting day +30 to +60- 30% MRD at time of transplant, 10% MRD at time of enrollment- AEs: Skin, cytopenia- No significant difference in GVHD- No FLT3-TKI prior to HCT. The gene discussed is FLT3; the disease is graft versus host disease.